These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4190202)

  • 61. Coagulation abnormalities in women taking oral contraceptives.
    Carvalho AC; Vaillancourt RA; Cabral RB; Lees RS; Colman RW
    JAMA; 1977 Feb; 237(9):875-8. PubMed ID: 576325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [What do oral contraceptives do? What are oral contraceptives?].
    Rignell S
    Nord Med; 1971 Oct; 86(40):1168. PubMed ID: 5131957
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Eruptions due to oral contraceptives.
    Coskey RJ
    Arch Dermatol; 1977 Mar; 113(3):333-4. PubMed ID: 843100
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cryofibrinogenaemia and acute gangrene in systemic sclerosis.
    Barrett MC; Prendiville JS; Pardy BJ; Cream JJ
    Postgrad Med J; 1986 Oct; 62(732):935-6. PubMed ID: 3774725
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro and in vivo effects of heparin on cryofibrinogen.
    Komp DM; Donaldson MH
    N Engl J Med; 1968 Dec; 279(26):1439-40. PubMed ID: 5722919
    [No Abstract]   [Full Text] [Related]  

  • 66. [Vasculorenal risks of oral contraceptives].
    Kanfer A
    Rev Prat; 1977 Apr; 27(23):1507-10. PubMed ID: 866957
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Update on oral contraceptives.
    Hanson M; Hatcher RA; Mishell DR; Notelovitz M; Spellacy WN
    J Reprod Med; 1985 Sep; 30(9 Suppl):691-713. PubMed ID: 4057184
    [No Abstract]   [Full Text] [Related]  

  • 68. [Status of oral contraceptives as a risk factor in cerebrovascular diseases].
    Auff E; Zeiler K; Holzner F; Wimmer S; Deecke L
    Wien Klin Wochenschr; 1986 May; 98(10):304-10. PubMed ID: 3727590
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Behavior of heparinocytes and of fibrinolytic degradation products after discontinuation of hormonal contraceptives].
    Frick G; Göretzlehner G; Frick U
    Zentralbl Gynakol; 1976; 98(15):908-13. PubMed ID: 969999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dapsone and severe hypoalbuminaemia. A report of two cases.
    Kingham JG; Swain P; Swarbrick ET; Walker JG; Dawson AM
    Lancet; 1979 Sep; 2(8144):662-4. PubMed ID: 90758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C.
    Lolin Y; Razis PA; O'Gorman P; Hjelm M; Wierzbicki AS
    J Med Genet; 1989 Oct; 26(10):631-6. PubMed ID: 2585459
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complications of oral contraceptive agents--a symposim. Contraceptives and lipid metabolism.
    Fiser RH
    West J Med; 1975 Jan; 122(1):35-8. PubMed ID: 162816
    [No Abstract]   [Full Text] [Related]  

  • 73. Cryofibrinogenaemia in patients on oral contraceptives.
    Ritzmann SE
    Lancet; 1970 Mar; 1(7645):522. PubMed ID: 4190202
    [No Abstract]   [Full Text] [Related]  

  • 74. Cryofibrinogenaemia in women using oral contraceptives.
    Fisch IR
    Lancet; 1970 Apr; 1(7650):775. PubMed ID: 4191265
    [No Abstract]   [Full Text] [Related]  

  • 75. Cryofibrinogenaemia in women using oral contraceptives.
    Farrell G; Stuckey RJ; Wolf P
    Lancet; 1970 May; 1(7653):952-3. PubMed ID: 4191581
    [No Abstract]   [Full Text] [Related]  

  • 76. Cryofibrinogen and oral contraception in women.
    Lee RS
    J Am Osteopath Assoc; 1973 Aug; 72(12):1161-5. PubMed ID: 4490261
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.